Core Viewpoint - Lanxess reported a decline in sales and adjusted its financial outlook due to weak global market demand, while continuing its transformation towards specialty chemicals [1][2] Group 1: Financial Performance - In the first half of 2025, Lanxess achieved sales of approximately €3.067 billion, a year-on-year decrease of 7% [1] - The EBITDA for the same period was around €283 million, remaining stable compared to the previous year [1] - The company generated a positive free cash flow of €31 million in the second quarter despite challenging market conditions [2] Group 2: Business Transformation - On April 1, 2025, Lanxess sold its polyurethane systems business to Ube Industries, marking the final step in its transition to specialty chemicals [1] - The proceeds from the sale will be used to redeem €500 million benchmark bonds maturing in May 2025, reducing net financial debt from €2.512 billion in Q1 2025 to €2.069 billion in Q2 2025, an 18% decrease [1] Group 3: Operational Adjustments - To address the ongoing weak demand, Lanxess is optimizing its global production network, including the early closure of the hexane oxidation facility in Krefeld-Uerdingen by the end of Q2 2025 [2] - The company has adjusted its 2025 EBITDA guidance to a range of €520 million to €580 million, down from the previous expectation of €600 million to €650 million, factoring in a €10 million burden from a chlorine supplier's supply constraints [2] - Lanxess plans to streamline its global aromatic chemicals plant network and will close the production site in Widnes, UK, by 2026 due to high operational costs [2]
朗盛下调全年盈利预期 采取积极措施应对市场需求疲软
Zheng Quan Ri Bao Wang·2025-08-19 13:15